Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

7.30
+0.02000.27%
Post-market: 7.350.0514+0.70%19:59 EDT
Volume:963.56K
Turnover:7.05M
Market Cap:125.20M
PE:-0.58
High:7.54
Open:7.27
Low:7.09
Close:7.28
52wk High:23.06
52wk Low:7.09
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.77
T/O Rate:6.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.56
PE(LYR):-0.50

Loading ...

Oct 02, 2026

Major Issues Report

Form 8-K - Current report
Sep 22, 2026

Major Issues Report

Form 8-K - Current report
Sep 08, 2026

Major Issues Report

Form 8-K - Current report
Aug 19, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 21, 2026

Major Issues Report

Form 8-K - Current report
Jul 13, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 08, 2026

Major Issues Report

Form 8-K - Current report
May 27, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]